Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Takeda’s obesity drug Contrave launches in US

Clears cardiovascular safety hurdle to be third new weight-loss drug in recent months

- PMLiVE

NICE backs GSK’s Tafinlar for skin cancer

Joins Yervoy and Zelboraf as a recommended melanoma treatment

- PMLiVE

‘Millennials’ turning to self-diagnosis, says report

And mental health is an increasing priority

- PMLiVE

Amgen appoints R Sanders Williams to board of directors

He is president of Gladstone Institutes

- PMLiVE

Pressure put on Roche to cut Kadcyla’s UK price

30,000 people sign petition to help make the breast cancer drug available on the NHS

- PMLiVE

Pharma lobbying in the US

Is it a matter of freedom of speech?

Novartis building

FDA panel backs Novartis’ secukinumab for psoriasis

Drug has outperformed Amgen’s Enbrel in clinical trials

- PMLiVE

AbbVie and Shire bring merger plans to a close

Blames tax changes in the US

- PMLiVE

EMA offers orphan drug benefits for Ebola research

Incentives to encourage development of new treatments for the virus

- PMLiVE

Salary survey now open – how will you measure up?

Take part for a chance to win a Kindle Fire HD tablet

- PMLiVE

Parkinson’s UK appoints Arthur Roach as research director

He brings experience from Merck Serono and the Geneva Pharma Network

- PMLiVE

Red Door promotes Matt Lowe and Katy Pogson

Kate Aldous and Sarah Aldridge also move up at the Creston Health agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links